Copyright Reports & Markets. All rights reserved.

Global Chronic Idiopathic Constipation Drugs Market Research Report 2012-2024

Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Linaclotide
        • 1.2.1.2 Lubiprostone
        • 1.2.1.3 Others
      • 1.2.2 by Application
        • 1.2.2.1 Hospital Pharmacies
        • 1.2.2.2 Retail Pharmacies
        • 1.2.2.3 Online Pharmacies
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Linaclotide Market, 2013-2018
      • 4.1.2 Lubiprostone Market, 2013-2018
      • 4.1.3 Others Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Linaclotide Market Forecast, 2019-2024
      • 4.2.2 Lubiprostone Market Forecast, 2019-2024
      • 4.2.3 Others Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Hospital Pharmacies Market, 2013-2018
      • 5.1.2 Retail Pharmacies Market, 2013-2018
      • 5.1.3 Online Pharmacies Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Hospital Pharmacies Market Forecast, 2019-2024
      • 5.2.2 Retail Pharmacies Market Forecast, 2019-2024
      • 5.2.3 Online Pharmacies Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Pfizer
    • 8.2 Glaxosmithkline
    • 8.3 Roche Holding AG
    • 8.4 Sanofi
    • 8.5 Bayer AG
    • 8.6 Merck
    • 8.7 Eli Lilly
    • 8.8 Allergens
    • 8.9 Chugai Pharmaceutical
    • 8.10 Ferring International Center S.A
    • 8.11 Synergy Pharmaceuticals
    • 8.12 Salix Pharmaceuticals Ltd
    • 8.13 Sucampo Pharmaceuticals Inc
    • 8.14 Ironwood Pharmaceuticals Inc
    • 8.15 Valeant Pharmaceuticals International
    • 8.16 Daiichi Sankyo
    • 8.17 Cosmo Pharmaceuticals SA
    • 8.18 Progenics Pharmaceuticals Inc
    • 8.19 Theravance Biopharma Inc

    9 Conclusion

    Summary
    The global Chronic Idiopathic Constipation Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Linaclotide 
    Lubiprostone 
    Others
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Pfizer 
    Glaxosmithkline 
    Roche Holding AG 
    Sanofi 
    Bayer AG 
    Merck 
    Eli Lilly 
    Allergens 
    Chugai Pharmaceutical 
    Ferring International Center S.A 
    Synergy Pharmaceuticals 
    Salix Pharmaceuticals Ltd 
    Sucampo Pharmaceuticals Inc 
    Ironwood Pharmaceuticals Inc 
    Valeant Pharmaceuticals International 
    Daiichi Sankyo 
    Cosmo Pharmaceuticals SA 
    Progenics Pharmaceuticals Inc 
    Theravance Biopharma Inc
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Hospital Pharmacies 
    Retail Pharmacies 
    Online Pharmacies
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now